Treatment of primary palmar hyperhidrosis - Trial PACTR202006915898923
Access comprehensive clinical trial information for PACTR202006915898923 through Pure Global AI's free database. This Not Applicable trial is sponsored by Mansoura university faculty of medicine and is currently Recruitment Completed. The study focuses on Skin and Connective Tissue Diseases.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Mansoura university faculty of medicine
Heba Shawky Attallah Elsayed
Timeline & Enrollment
Not Applicable
May 25, 2016
Nov 15, 2020
Summary
Palmar hyperhidrosis is characterized by excessive sweating beyond the physiological needs of the patient's body and the most frequent form is primary or essential. Different treatments protocols have been proposed to control or decrease sweating. This study aimed to compare the efficacy and safety of oral oxybutynin versus topical aluminum chloride hexahydrate (ACH) in treating primary palmar hyperhidrosis. Also, to assess quality of life (QOL) as a measure of improvement in hyperhidrosis state.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR202006915898923
Non-Device Trial